This limits GLP-1's ability to effectively regulate blood sugar, particularly in those with impaired glucose metabolism and insulin resistance
[Abstract] FDA
How genetics shape the GLP-1 experience Side-effect tolerability is shaped by many factors, including dose-escalation strategy, baseline gastrointestinal motility, hydration status, concurrent medications, prior GLP-1 exposure, metabolic health, and individual biology
These sensory changes are usually temporary and tend to resolve as the body adapts to the therapy
In the cytosol, Cyt c, Apaf-1, and dATP form the apoptosome, which activates caspase-9, thereby initiating a proteolytic cascade involving effector caspases like caspase-3 (9)